Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies, including Hims & Hers and other compounding pharmacies, as similar alternatives to FDA-approved drugs. The agency said the actions are intended to safeguard consumers from drugs for which the FDA cannot verify quality, safety, or efficacy. The agency also emphasized ongoing concerns around promotional claims and direct-to-consumer messaging, building on the The FDA is also taking steps to combat misleading direct-to-consumer advertising and marketing following warning letters that were sent in the fall of 2025, the agency said
Understanding these behavioral patterns helps clinicians reinforce realistic expectations
Yamamoto Nutrition Carnitine 1000 is a dietary supplement of Carnitine in 1000 mg tablets, (carnitine tartrate), useful in cases of reduced dietary intake of this nutrient
Diab Obes
Payment Plans Visit our YouTube channel for FAQs, tips, tricks, and latest research
Additionally, spinach, broccoli, and potatoes all contain alpha-lipoic acid, which may aid your body in recycling this antioxidant